Starling Oncology Debt-to-Assets Ratio Growth & History (STLN)

Starling Oncology's debt-to-assets ratio was 0.63 for fiscal 2025.

View full Starling Oncology company overview

Starling Oncology annual debt-to-assets ratio history

Starling Oncology annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20252025-12-310.63−0.08−11.70%
20242024-12-310.710.14+24.62%
20232023-12-310.570.16+38.20%
20222022-12-310.410.41+30112.99%
20212021-12-310.00−0.18−99.25%
20202020-12-310.18

Starling Oncology debt-to-assets ratio trends

Over the last five fiscal years, Starling Oncology's debt-to-assets ratio increased from 0.18 to 0.63, a change of 0.45. The latest reported quarter, Q2 2026, shows 0.59.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Starling Oncology source filings ↗

Community posts

It’s quiet here.

No posts about STLN yet. Start the conversation.

Write the first post